Thijssen Ayla, Schreuder Ramon-Michel, Dehghani Nikoo, Schor Marieke, de With Peter H N, van der Sommen Fons, Boonstra Jurjen J, Moons Leon M G, Schoon Erik J
GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands.
Department of Gastroenterology and Hepatology, Maastricht Universitair Medisch Centrum+, Maastricht, Netherlands.
Endosc Int Open. 2024 Oct 10;12(10):E1102-E1117. doi: 10.1055/a-2403-3103. eCollection 2024 Oct.
Artificial intelligence (AI) has great potential to improve endoscopic recognition of early stage colorectal carcinoma (CRC). This scoping review aimed to summarize current evidence on this topic, provide an overview of the methodologies currently used, and guide future research. A systematic search was performed following the PRISMA-Scr guideline. PubMed (including Medline), Scopus, Embase, IEEE Xplore, and ACM Digital Library were searched up to January 2024. Studies were eligible for inclusion when using AI for distinguishing CRC from colorectal polyps on endoscopic imaging, using histopathology as gold standard, reporting sensitivity, specificity, or accuracy as outcomes. Of 5024 screened articles, 26 were included. Computer-aided diagnosis (CADx) system classification categories ranged from two categories, such as lesions suitable or unsuitable for endoscopic resection, to five categories, such as hyperplastic polyp, sessile serrated lesion, adenoma, cancer, and other. The number of images used in testing databases varied from 69 to 84,585. Diagnostic performances were divergent, with sensitivities varying from 55.0% to 99.2%, specificities from 67.5% to 100% and accuracies from 74.4% to 94.4%. This review highlights that using AI to improve endoscopic recognition of early stage CRC is an upcoming research field. We introduced a suggestions list of essential subjects to report in research regarding the development of endoscopy CADx systems, aiming to facilitate more complete reporting and better comparability between studies. There is a knowledge gap regarding real-time CADx system performance during multicenter external validation. Future research should focus on development of CADx systems that can differentiate CRC from premalignant lesions, while providing an indication of invasion depth.
人工智能(AI)在提高早期结直肠癌(CRC)的内镜识别方面具有巨大潜力。本综述旨在总结该主题的现有证据,概述当前使用的方法,并指导未来的研究。按照PRISMA-Scr指南进行了系统检索。截至2024年1月,对PubMed(包括Medline)、Scopus、Embase、IEEE Xplore和ACM数字图书馆进行了检索。当研究使用人工智能在内镜成像上区分结直肠癌和结直肠息肉,以组织病理学作为金标准,报告敏感性、特异性或准确性作为结果时,这些研究有资格纳入。在筛选的5024篇文章中,纳入了26篇。计算机辅助诊断(CADx)系统的分类类别从两类,如适合或不适合内镜切除的病变,到五类,如增生性息肉、无蒂锯齿状病变、腺瘤、癌症和其他。测试数据库中使用的图像数量从69到84585不等。诊断性能各不相同,敏感性从55.0%到99.2%,特异性从67.5%到100%,准确性从74.4%到94.4%。本综述强调,使用人工智能提高早期结直肠癌的内镜识别是一个新兴的研究领域。我们介绍了一份关于内镜CADx系统开发研究中应报告的重要主题的建议清单,旨在促进更完整的报告以及研究之间更好的可比性。在多中心外部验证期间,关于实时CADx系统性能存在知识空白。未来的研究应侧重于开发能够区分结直肠癌和癌前病变,同时提供浸润深度指示的CADx系统。